A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 5/2/2012

Posted by | 10:56pm on Wednesday, May 2, 2012

:
Thanks to @: from @ for moderating #socpharm chat tonight. Everyone is welcome to join in!

:
We’ll assume that all tweets represent your own views & not that of your employer or clients. #socpharm

:
Looking forward to the conversation! #socpharm

:
hi! excited to join tonight’s #socpharm tweetchat #SocPharm

:
Looking forward to the conversation! #socpharm

:
Welcome! Tx 4joining. Let’s start with T1: Pinterest &health & some early pharmaco tries from Bayer & Novo http://t.co/5BCILn38 #socpharm

:
Anyone else having tweet delays for their messages to show up in stream? #socpharm

:
T1: Given commenting etc. is it something pharma should consider? anyone using Pinterest 4 their own prof. use? #socpharm

:
@ Yes, I am too #socpharm

:
Hi #socpharm ‘ers!

:
@ experiencing some delays on my end too… #SocPharm

:
@: welcome! thanks for joining #socpharm

:
T1: Think it will be interesting to see how pharma evolves on Pinterest. Good for @ & Bayer to take part. #socpharm

:
T1: Check out @ post Do You Need an Infographic Strategy? http://t.co/1mz3V5CB #socpharm

:
T1: Beside copyright concerns with Pinterest, don’t see where pharma can easily post “terms of use” re acceptable comments. #socpharm

:
@: that’s great – visual is so powerful for health. but yes comments, copyright present probs 4 pharma #socpharm

:
@: John makes a valid point in his post about the need 4 pharma to provide patient support thru every channel. #socpharm

:
Infographics would be a great use of Pinterest boards but w/o a way to delete comments IDK how many pharmas will take part #socpharm

:
also curious to see how pharma approaches,could be interesting if brands w nutritional focus(eg,diabetes) pinned their own recipes #SocPharm

:
@: True but so few are equipped to now #socpharm

:
T1: Agree with @ that disease awareness infographics would be great for pharma to share on Pinterest. #socpharm

:
Thrilled to join first #socpharm chat

:
T2: @ shared this infographic on the neurology of gaming http://t.co/1DqNxaHc #socpharm

:
t2: Insurers seem keen on health gaming http://t.co/nVUpk93G & we’ve seen some pharma health games http://t.co/2Ltxz9Ys #socpharm

:
T2: Anyone seen metrics on success of health games in an adult population? Are any compelling enough to have an effect? #socpharm

:
gr8 idea-Paula Deen Novartis board? MT @: : could b interesting if brands w nutritional focus(diabetes) pinned recipes #SocPharm

:
@ Welcome so glad you could join. We always like physician perspective at #socpharm

:
That is the question. I haven’t RT @: : T2: Anyone seen metrics on success of health games in an adult population? #socpharm

:
T2 We see avid casual game use among older, female audience – but r health games compelling enough? #socpharm

:
T2: I’m not a gamer but lots of people are, including a surprising percentage of “mature” women. #socpharm

:
T2 I like my angry birds and words with friends, but i can’t see myself playing health games. #socpharm

:
@: look forward to contributing! Have a particular interest in ways #medicalaffairs can engage #socpharm

:
@: Could be more compelling when results align with a wellness program and impact cost of insurance premiums. #socpharm

:
Good evening #socpharm. Dana Webster joining a little late

:
T2: I might be motivated if I got starbucks rewards like in WSJ article :-) http://t.co/kbNXNjiL #SocPharm

:
Have seen limited perspectives from #clinicaldevelopment & #medicalaffairs #socpharm

:
http://t.co/45KP63n3 I think it makes a good pt, end “goal” of game must be defined app itself is not end all be all #socpharm

:
#socpharm hello.jumping in. data on games that create behavior change?

:
@: @: – true – combining two powerful motivators! #socpharm

:
Anyone know how effective @ Facebook app (https://t.co/CzUggqxF) has been? It’s very nicely done #socpharm

:
@: great to have you. Perhaps will throw out T3 for you – http://t.co/g5DbPVDS PWC report on health/soc media #socpharm

:
@: I’m not sure how outcomes would be effectively measured #socpharm

:
LOL #socpharm RT @: T2 If I heard the word “gamification” of HC one more time peeps need to pass out anti emetics with it 2! :)

:
@: I’d just be curious if anyone actually plays them (although I imagine the sbux cards are motivating) #socpharm

:
Some use of Social Media to recruit patients @: Have seen limited perspectives from #clinicaldevelopment #medicalaffairs #socpharm

:
T3: Stat “34% said social media would affect their decision about taking a certain medication” shows the power & impact 4 pharma #socpharm

:
@: @: beyond clinical trial recruitment what other do u want to see from pharma (or what is feasible) #socpharm

:
Late to the party, but here I am tonight #SocPharm

:
@: Yes I have seen some models for patient recruitment; not widely adopted. #socpharm

:
@: Welcome Melissa! #socpharm

:
@: @: perhaps begin to explore ways to engage thought leaders #socpharm

:
Physician or Pt. FAQ responses @: MT @: beyond clinical trial recruitment what other feasible from pharma #socpharm

:
@: absolutely, whole idea of thought leadership has changed. not just KOLs – patient thought leaders, phys bloggers etc #socpharm

:
Would love to see a #MysteryDiagnosis brain game on social media for diagnosing #raredisease #SocPharm

:
@: thx for sharing this! Interesting survey; would be curious as to types of health info sought #socpharm

:
@: Ah that is the dream!despite all the OL content patients still struggle 2 get answers 4 their Q’s #socpharm

:
#socpharm @: I think a #MysteryDiagnosis game would be quite popular, based on the popularity alone of that show itself

:
@: brilliant. http://t.co/mGDw4ekU is quite popular, HIV puzzle solved by gamers http://t.co/A4icQmOI #socpharm

:
FdA approved linical trial data @: @: beyond clinical trial recruitment what other feasible from pharma #socpharm

:
@: Interesting idea. The Diagnosis column on NYTimes where they ask readers to take on difficult cases is v popular #socpharm

:
@: I’ll follow up after with some of our own results on how we see patients using social. v interesting evolution #socpharm

:
t3: as somone w/#raredisease, Social Media best to help me find other pts to relate to. Not as interested in engagement w/hosp #socpharm

:
Health bloggers have been tapped by Roche Diabetes very effectively. Most pharma scared to engage #socpharm

:
T3: Engaging w/health bloggers requires finesse. Have to b authentic & willing to hear good & bad. Agree Roche excellent example #socpharm

:
@: We see patients are OK w pharma involvement in communities when providing value. would u agree? #socpharm

:
I want to ask @: about engagement w/Pozen Pharma Digital Advisory Board http://t.co/ZVCgonhN Do u c others using this? #socpharm

:
@: @ has been fascinating to work with. Asking question of how to design a pharmaco for today’s digital world #socpharm

:
@: Yes. I have been in pharma for many yrs. If intent is to learn, completely fine w/me #socpharm

:
@: Diabetes is definitely an optimal disease for engaging bloggers; other disease state should be explored #socpharm

:
@ agree transparency and authenticity v.imp w/ bloggers or else can go like conagra example-http://tinyurl.com/6tpgj3o #socpharm

:
I think this is a trend we will see with smaller pharma, biotech – esp with niche focus. Question is when big pharma will catch up #socpharm

:
@: Diabetes communities are very active/established. As cancer survivor, there is much opportunity to learn from us, too #socpharm

:
@ @: caregiver bloggers are key for chronic disease engagement #socpharm

:
@: recently reminded how insurance used to be sold door2door – now GEICO sends us online. small cos can adapt #socpharm

:
@: Unfortunately, my cancer is rare. Few people out there to engage, fewer pharmas working on treatments for Hodgkins #socpharm

:
@: Right, a small startup has the opportunity (no history or baggage) to create a new biopharma model #socpharm

:
MT @: : agree transparency & authenticity v.imp w/ bloggers -conagra example-http://tinyurl.com/6tpgj3o #socpharm

:
@: Exactly – we’ll start to see the benefits of starting w clean slate #socpharm

:
Time flies! Thank you so much to all. As promised wanted to offer a sneak peek of some of our new phys data to wrap up #socpharm

:
Big story, as anticipated is huge leap in phys iPad #s & impact on workflow. >half of ipad docs use @ POC #socpharm

:
Big jump in EHR adoption of course, and surprisingly, drs not averse to pharma content/tools within EHR #socpharm

:
No surprise Apple continues to dominate in phys device adoption. Despite opposite w consumers, not the year for Android w docs #socpharm

:
@: look forward to more info! Enjoyed the conversation, will try to join more often #socpharm

:
@: Wow! Are docs using apps on iPads or websites for drug info? #socpharm

:
@: Great thank you so much for joining and for the great discussions #socpharm

:
Thanks to everyone for joining the #socpharm chat. BIG thanks to @: for moderating tonight. #socpharm

:
@: Both, depends on situation and what they’re looking for. Apps like Epoc for quick lookup; but still fair amt of web #socpharm

:
Please mark you calendars for the #socpharm chat next month, June 6, when @ from BMS will be moderating.

:
Thanks to everyone so much for joining, and especially big thanks to @: for having me! #socpharm

:
@: @ Oh terrific, looking forward to that! #socpharm

:
@: @: how are legal parameters addressed? #socpharm

:
I’ll post the #socpharm transcript tomorrow & tweet the link.

:
@ focus on advocacy and education, link to wellness and lifestyle education in womens health #socpharm http://t.co/sPN2aNRw

:
@ thanks for a great chat #socpharm

:
@: great chat thank you #socpharm

:
@: gr8 to meet you on #socpharm tonight

:
@: thank you so much for joining! #socpharm

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

One Pingback/Trackback

    04 May 2012 at 5:05pm
    Transcript from last #SocPharm ...
  • Eileen O'Brien
Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com